Hologic, Inc. (HOLX) Return on Assets (ROA): 6.28%
Is Hologic, Inc.’s return on assets (ROA) high or low?
Hologic, Inc.'s return on assets (ROA) of 6.28% is 47% below its 5-year average of 11.79%, near the low end of its 5-year range (4.99%–20.98%).
The return on assets (ROA) for Hologic, Inc. (HOLX) is 6.28% as of Tuesday, June 9, 2026. It is below its 12-month average by 15.70% (7.45%).
HOLX Return on Assets (ROA) Chart
HOLX Average Return on Assets (ROA) Chart
HOLX Current vs Average Return on Assets (ROA) Chart
HOLX Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
6.28%
RETURN ON ASSETS (ROA) AVG TTM
7.45%
RETURN ON ASSETS (ROA) AVG 3Y
8.56%
RETURN ON ASSETS (ROA) AVG 5Y
11.79%
RETURN ON ASSETS (ROA) AVG 10Y
7.66%
RETURN ON ASSETS (ROA) AVG 15Y
4.52%
RETURN ON ASSETS (ROA) AVG 20Y
2.45%
CURRENT VS TTM AVG
-15.70%
CURRENT VS 3Y AVG
-26.64%
CURRENT VS 5Y AVG
-46.72%
CURRENT VS 10Y AVG
-18.04%
CURRENT VS 15Y AVG
+39.05%
CURRENT VS 20Y AVG
+156.38%
HOLX Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hologic, Inc. (HOLX) | — | 6.28% | 7.45% | 8.56% | 11.79% |
| Moderna, Inc. (MRNA) | $18.94B | -22.87% | -24.02% | -10.32% | -0.33% |
| Align Technology, Inc. (ALGN) | $12.76B | 6.58% | 6.68% | 6.69% | 12.75% |
| BioNTech SE (BNTX) | $21.87B | -4.96% | -3.96% | 9.16% | 17.06% |
| Mettler-Toledo International Inc. (MTD) | $23.50B | 23.41% | 25.02% | 24.63% | 23.85% |
| Waters Corporation (WAT) | $24.19B | 12.66% | 13.34% | 15.53% | 17.15% |
| Charles River Laboratories International, Inc. (CRL) | $9.14B | -2.02% | -0.94% | 2.58% | 3.75% |
| Bio-Rad Laboratories, Inc. (BIO) | $8.03B | 7.18% | -6.26% | -11.14% | 1.46% |
| Veeva Systems Inc. (VEEV) | $27.37B | 10.12% | 9.93% | 9.72% | 10.43% |
| Hims & Hers Health, Inc. (HIMS) | $6.46B | 5.96% | 11.88% | 0.12% | -6.73% |
Asset Efficiency
ROA
6.3%
ROE
11.2%
Hologic, Inc. Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hologic, Inc. Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Hologic, Inc. (HOLX)?
- The return on assets (ROA) for HOLX stock is 6.28%.
- Is Hologic, Inc.'s return on assets (ROA) high or low?
- Hologic, Inc.'s return on assets (ROA) of 6.28% is 47% below its 5-year average of 11.79%, near the low end of its 5-year range (4.99%–20.98%).
- What is the TTM average return on assets (ROA) for Hologic, Inc. (HOLX)?
- The TTM average return on assets (ROA) for HOLX stock is 7.45%.
- What is the 3Y average return on assets (ROA) for Hologic, Inc. (HOLX)?
- The 3Y average return on assets (ROA) for HOLX stock is 8.56%.
- What is the 5Y average return on assets (ROA) for Hologic, Inc. (HOLX)?
- The 5Y average return on assets (ROA) for HOLX stock is 11.79%.
- What is the 10Y average return on assets (ROA) for Hologic, Inc. (HOLX)?
- The 10Y average return on assets (ROA) for HOLX stock is 7.66%.
- What is the 15Y average return on assets (ROA) for Hologic, Inc. (HOLX)?
- The 15Y average return on assets (ROA) for HOLX stock is 4.52%.
- What is the 20Y average return on assets (ROA) for Hologic, Inc. (HOLX)?
- The 20Y average return on assets (ROA) for HOLX stock is 2.45%.
Hologic, Inc. Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-27 | 6.28% |
| 2024-09-30 | 8.62% |
| 2023-09-30 | 4.99% |
| 2022-09-30 | 14.35% |
| 2021-09-30 | 20.98% |
| 2020-09-30 | 15.50% |
| 2019-09-30 | -0.61% |
| 2018-09-30 | -1.54% |
| 2017-09-30 | 9.47% |
| 2016-09-30 | 4.52% |
| 2015-09-30 | 1.72% |
| 2014-09-30 | 0.21% |
| 2013-09-30 | -13.03% |
| 2012-09-30 | -0.70% |
| 2011-09-30 | 2.62% |
| 2010-09-30 | -1.12% |
| 2009-09-30 | -38.25% |
| 2008-09-30 | -4.74% |
| 2007-09-30 | 8.87% |
| 2006-09-30 | 3.20% |
| 2005-09-30 | 10.10% |
| 2004-09-30 | 5.74% |
| 2003-09-30 | 1.53% |
| 2002-09-30 | 0.10% |
| 2001-09-30 | -10.69% |
| 2000-09-30 | -8.48% |
| 1999-09-30 | -2.10% |
| 1998-09-30 | 6.03% |
| 1997-09-30 | 12.23% |
| 1996-09-30 | 9.26% |
Related Metrics
About Hologic, Inc.
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Malenchini